SyntekaBio Company Description

SyntekaBio, Inc. operates as an artificial intelligence new drug development company based on genomic big data primarily in South Korea.

It derives new drug candidates using DeepMatcher, an AI drug development platform that combines new drug development technology and genomic big data technology.

The company also researches and develops biomarker detection for individual cancer drug screening, disease susceptibility, immune typing, pharmacogenomic typing, and multi-omics information-based drug side effect prediction technology.

The company was founded in 2009 and is headquartered in Daejeon, South Korea.

SyntekaBio, Inc.

Country	South Korea
Founded	2009
Industry	Computer Programming, Data Processing, And Other Computer Related Services
Employees	62

Contact Details

Address: 1903, 1, Expo Tower Daejeon South Korea
Phone	82 70 7663 0958
Website	syntekabio.com

Stock Details

Ticker Symbol	226330
Exchange	KOSDAQ
Fiscal Year	January - December
Reporting Currency	KRW
SIC Code	7370